Azaindoles Useful as Inhibitors of JAK and other Protein Kinases

Details for Australian Patent Application No. 2012203384 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Salituro, Francesco; Farmer, Luc; Bethiel, Randy; Harrington, Edmund; Green, Jeremy; Court, John; Come, Jon; Lauffer, David; Aronov, Alex; Binch, Hayley; Boyall, Dean; Charrier, JeanDamien; Everitt, Simon; Fraysse, Damien; Mortimore, Michael; Pierard, Francoise; Robinson, Daniel; Wang, Jian; Pinder, Joanne; Wang, Tianshen; Pierce, Albert

Agent Cullens

Pub. Number AU-A-2012203384

Parent 2005228904

Filing date 8 June 2012

Wipo publication date 28 June 2012

International Classifications

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 519/00 Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

28 June 2012 Application Open to Public Inspection

  Published as AU-A-2012203384

28 June 2012 Complete Application Filed

2 August 2012 Corrigenda

  Applications OPI - Name Index Under the name Vertex Pharmaceuticals Incorporated, Application No. 2012203384, under INID (72) correct the co-inventor to Wang, Tiansheng

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012203385-Retractable Pergola with Photovoltaic Cell Panels

2012203383-A horticultural mat